ThyroidSupport `{pregnancy.edition}` · the first step of the patient-data wizard (gestational week · weight · age), Greek UI. No patient identifiers; sample values shown.
Ethics: 424 GMH IRB · Αριθμ. Πρωτ. 43773 · Interim · not for clinical use.
Protocol summary
ThyroidSupport {pregnancy.edition} is a patient-facing application — runs in
the browser on desktop and on mobile — that translates the thyroid-in-pregnancy
guideline corpus into computable, trimester-aware dose suggestions for the
patient and her care team. It is not a self-care tool: every output is presented
as a suggestion that requires the supervising physician's explicit approval
before acting. CE-grade is the regulatory target.
Who it is for. Pregnant women already taking levothyroxine, including after total or near-total thyroidectomy for benign disease. Treatment-naive patients, and patients after lobectomy or surgery for thyroid cancer, are outside its scope; the application asks about treatment and surgery first and ends there for anyone out of scope.
Inputs are the current levothyroxine treatment, thyroid-surgery history, gestational age and TSH.
The application is registered on the Open Science Framework (OSF, DOI 10.17605/OSF.IO/6SKZ2) and the protocol has been approved by the Scientific Council of the 424 General Military Hospital of Thessaloniki (see Ethics & governance, opposite).
Where we are
Formative usability studies are open. The current readout is qualitative — clinician fit, patient comprehension, surfacing of the right alerts at the right moment, time-on-task — alongside quantitative concordance with the underlying guideline.
A public protocol and interim-results paper is targeted for Q1 2027. The
sibling edition for fertility intake is documented at ThyroidSupport {preconception.edition}.